Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Amyloid beta-peptide has been demonstrated to be toxic for primary and clonal neuronal cell lines in vitro. Oxidative mechanisms have been implicated in this pathway at several points, including the aggregation of beta-amyloid necessary for cytotoxic activity, generation of radicals by the peptide itself, and intracellularly in response to toxic beta-amyloid peptides. Supporting an oxidative hypothesis are the observations that cells mount a stress response to beta-amyloid similar to that seen in response to oxidative stress and that they may be rescued from cytotoxicity by antioxidants, inhibitors of oxidative enzyme metabolism, and overexpression of antioxidant enzymes. Although the source(s) of the oxygen radicals has not yet been identified, altered antioxidant enzyme levels and oxidative by-products in Alzheimer's disease brain samples relate the in vitro studies to the human disease.


Journal article



Publication Date





441 - 444


Amyloid beta-Peptides, Apoptosis, Cell Death, Humans, Neurons, Oxidation-Reduction, Peptide Fragments, Reactive Oxygen Species, Receptors, Cell Surface